[1]
Bersanelli, M. et al. 2019. Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab. Acta Biomedica Atenei Parmensis. 90, 4 (Dec. 2019), 468–474. DOI:https://doi.org/10.23750/abm.v90i4.7057.